Krilogy Financial LLC Dynavax Technologies Corp Transaction History

Krilogy Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $1,628 - $2,656	-200 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$11.85 - $16.0 $2,370 - $3,200	200 New	200 $2,000
Q2 2018 Aug 15, 2018	SELL	$15.15 - $20.75 $3,030 - $4,150	-200 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	200	200 $2,000

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.